Detalhe da pesquisa
1.
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
J Oncol Pharm Pract
; 26(1): 74-92, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917738
2.
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
Cancer Chemother Pharmacol
; 87(6): 817-826, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677674
3.
Increased body mass index is a risk factor for acute promyelocytic leukemia.
EJHaem
; 2(1): 33-39, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693438
4.
High dose cytarabine, mitoxantrone, pegasapargase (HAM-pegA) in combination with dasatinib for the first-line treatment of Philadelphia chromosome positive mixed phenotype acute leukemia.
Am J Leuk Res
; 4(1)2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33283208
5.
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia.
J Clin Med
; 9(2)2020 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079074
6.
A Retrospective Analysis of Prolonged Empiric Antibiotic Therapy for Pneumonia Among Adult Neurocritical Care Patients.
Neurohospitalist
; 9(1): 15-21, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30671159
7.
Comparison of prescribing patterns between United States and Dominican Republic prescribers on short-term medical mission trips.
Int Health
; 10(1): 27-32, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309591